4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-100320
Chief Medical Officer sold 937 shares at $6.98 ($6,540)
- Chief Medical Officer acquired 937 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nichols William Garrett Chief Medical Officer | 2025-07-28 | Option exercise 10b5-1 | +937 | $1.29 | $1,209 | 53,430 | D |
| Nichols William Garrett Chief Medical Officer | 2025-07-28 | Sale 10b5-1 | −937 | $6.98 | $6,540 | 52,493 | D |
| Derivatives | |||||||
| Nichols William Garrett Chief Medical Officer | 2025-07-28 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −937 | 29,377 | D | ||
| Open-market sales · 937 sh · avg $6.98 · $6,540 | |||||||
Loading xslF345X05/ownership.xml…